ヘルスケア/医療シミュレーションの世界市場予測(~2027年)

• 英文タイトル:Healthcare/Medical Simulation Market Research Report by Product & service, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Healthcare/Medical Simulation Market Research Report by Product & service, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「ヘルスケア/医療シミュレーションの世界市場予測(~2027年)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301A089
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、226ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査資料では、2021年に1,806.25百万ドルであった世界のヘルスケア/医療シミュレーション市場規模が、2022年に2,135.34百万ドルに到達し、2027年まで年平均18.47%で成長して4,995.02百万ドルまで拡大すると予想しています。本資料は、ヘルスケア/医療シミュレーションの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品&サービス別(医療シミュレーション用解剖モデル、医療シミュレーション用ソフトウェア、シミュレーショントレーニングサービス、Web型シミュレーション)分析、エンドユーザー別(学術機関、病院、軍事機関)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などを以下の構成で整理しています。また、Adam,Rouilly Limited、Advanced Electronic Devices Inc.、Altay Scientific Group S.r.l.、Altay Scientific SpA、CAE Inc.、Cardionic Inc.、Epona Medicalなどの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト

・世界のヘルスケア/医療シミュレーション市場規模:製品&サービス別
- 医療シミュレーション用解剖モデルの市場規模
- 医療シミュレーション用ソフトウェアの市場規模
- シミュレーショントレーニングサービスの市場規模
- Web型シミュレーションの市場規模

・世界のヘルスケア/医療シミュレーション市場規模:エンドユーザー別
- 学術機関における場規模
- 病院における場規模
- 軍事機関における場規模

・世界のヘルスケア/医療シミュレーション市場規模:地域別
- 南北アメリカのヘルスケア/医療シミュレーション市場規模
アメリカのヘルスケア/医療シミュレーション市場規模
カナダのヘルスケア/医療シミュレーション市場規模
ブラジルのヘルスケア/医療シミュレーション市場規模

- アジア太平洋のヘルスケア/医療シミュレーション市場規模
中国のヘルスケア/医療シミュレーション市場規模
インドのヘルスケア/医療シミュレーション市場規模
韓国のヘルスケア/医療シミュレーション市場規模
台湾のヘルスケア/医療シミュレーション市場規模

- ヨーロッパ/中東/アフリカのヘルスケア/医療シミュレーション市場規模
イギリスのヘルスケア/医療シミュレーション市場規模
ドイツのヘルスケア/医療シミュレーション市場規模
フランスのヘルスケア/医療シミュレーション市場規模
ロシアのヘルスケア/医療シミュレーション市場規模

- その他地域のヘルスケア/医療シミュレーション市場規模

・競争状況
・企業情報

The Global Healthcare/Medical Simulation Market size was estimated at USD 1,806.25 million in 2021 and expected to reach USD 2,135.34 million in 2022, and is projected to grow at a CAGR 18.47% to reach USD 4,995.02 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Healthcare/Medical Simulation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product & service, the market was studied across Medical simulation anatomical models, Medical Simulation Software, Simulation Training Services, and Web-Based Simulation. The Medical simulation anatomical models is further studied across Dental Simulators, Endovascular Simulators, Eye Simulators, Interventional Surgical Simulators, Patient Simulators, Task Trainer, and Ultrasound Simulators. The Interventional Surgical Simulators is further studied across Cardiovascular Simulators, Gynecology Simulators, Laparoscopic Surgical Simulators, Orthopedic Simulators, and Spine Surgical Simulators. The Patient Simulators is further studied across High Fidelity Simulators, Low Fidelity Simulators, and Medium Fidelity Simulators. The Medical Simulation Software is further studied across Performance Recording Software and Virtual Tutors. The Simulation Training Services is further studied across Custom Consulting Services, Education Societies, and Vendor Based Training.

Based on End-User, the market was studied across Academic Institutes, Hospitals, and Military Organizations.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Healthcare/Medical Simulation market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare/Medical Simulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare/Medical Simulation Market, including Adam,Rouilly Limited, Advanced Electronic Devices Inc., Altay Scientific Group S.r.l., Altay Scientific SpA, CAE Inc., Cardionic Inc., Epona Medical, Gaumard Scientific Company, Inc., Intelligent Ultrasound Group Plc, KaVo Dental GmbH, Kyoto Kagaku Co. Ltd., Laerdal Medical GmbH, Limbs & Things Ltd., Mentice AB, Operative Experience Inc., Simulab Corporation, Simulaids Inc., Surgical Science Sweden AB, VirtaMed AG, and Yuan Technology Limited.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Healthcare/Medical Simulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare/Medical Simulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare/Medical Simulation Market?
4. What is the competitive strategic window for opportunities in the Global Healthcare/Medical Simulation Market?
5. What are the technology trends and regulatory frameworks in the Global Healthcare/Medical Simulation Market?
6. What is the market share of the leading vendors in the Global Healthcare/Medical Simulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Healthcare/Medical Simulation Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to build skilled healthcare staff worldwide
5.1.1.2. Rise in target population to enhance customer care with treatments
5.1.1.3. Surge in demand to achieve enhanced clinical decision making
5.1.2. Restraints
5.1.2.1. High capital investment coupled with unavailability of governmental funding
5.1.3. Opportunities
5.1.3.1. Ongoing higher private fundings in healthcare sectors
5.1.3.2. Emerging simulation technologies along with rising awareness towards hospital care management
5.1.3.3. Growing popularity of virtual training with higher acquisition of clinical skills through hands-on practice
5.1.4. Challenges
5.1.4.1. Stringent rules and regulations associated with healthcare simulation
5.2. Cumulative Impact of COVID-19

6. Healthcare/Medical Simulation Market, by Product & service
6.1. Introduction
6.2. Medical simulation anatomical models
6.3.1. Dental Simulators
6.3.2. Endovascular Simulators
6.3.3. Eye Simulators
6.3.4. Interventional Surgical Simulators
6.3.5.1. Cardiovascular Simulators
6.3.5.2. Gynecology Simulators
6.3.5.3. Laparoscopic Surgical Simulators
6.3.5.4. Orthopedic Simulators
6.3.5.5. Spine Surgical Simulators
6.3.5. Patient Simulators
6.3.6.1. High Fidelity Simulators
6.3.6.2. Low Fidelity Simulators
6.3.6.3. Medium Fidelity Simulators
6.3.6. Task Trainer
6.3.7. Ultrasound Simulators
6.3. Medical Simulation Software
6.4.1. Performance Recording Software
6.4.2. Virtual Tutors
6.4. Simulation Training Services
6.5.1. Custom Consulting Services
6.5.2. Education Societies
6.5.3. Vendor Based Training
6.5. Web-Based Simulation

7. Healthcare/Medical Simulation Market, by End-User
7.1. Introduction
7.2. Academic Institutes
7.3. Hospitals
7.4. Military Organizations

8. Americas Healthcare/Medical Simulation Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Healthcare/Medical Simulation Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Healthcare/Medical Simulation Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Adam,Rouilly Limited
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Advanced Electronic Devices Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Altay Scientific Group S.r.l.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Altay Scientific SpA
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. CAE Inc.
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Cardionic Inc.
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Epona Medical
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Gaumard Scientific Company, Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Intelligent Ultrasound Group Plc
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. KaVo Dental GmbH
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Kyoto Kagaku Co. Ltd.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Laerdal Medical GmbH
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Limbs & Things Ltd.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Mentice AB
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Operative Experience Inc.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Simulab Corporation
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Simulaids Inc.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Surgical Science Sweden AB
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. VirtaMed AG
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Yuan Technology Limited
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing




• 英文レポート名:Healthcare/Medical Simulation Market Research Report by Product & service, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:ヘルスケア/医療シミュレーションの世界市場予測(~2027年)
• レポートコード:MRC2301A089お問い合わせ(見積依頼・ご注文・質問)